Literature DB >> 3232125

Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activity.

J M Walenga1, M Petitou, M Samama, J Fareed, J Choay.   

Abstract

Previous theoretical and experimental evidence led to the formulation of a specific pentasaccharide structure which represents the site in heparin for binding to antithrombin III. This pentasaccharide was subsequently synthesized. A pentasaccharide of the same structure but lacking only the sulfate group on the hydroxyl group of the middle glucosamine (position C-3) was also synthesized to test the structure - activity relationships. Previous biochemical studies showed the 3-O-desulfated pentasaccharide to have a low affinity binding to AT III and to be devoid of the high anti-factor Xa activity characteristic of the pentasaccharide. Our in vivo studies, in a venous stasis thrombosis model proved the 3-O-desulfated pentasaccharide, at equigravimetric dosages, to be devoid of the antithrombotic activity previously reported for the pentasaccharide. These studies confirm the fact that inhibition of factor Xa at a high level of activity produces an antithrombotic effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3232125     DOI: 10.1016/0049-3848(88)90128-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Structural and functional characterization of a highly specific serpin in the insect innate immunity.

Authors:  Sun Hee Park; Rui Jiang; Shunfu Piao; Bing Zhang; Eun-Hye Kim; Hyun-Mi Kwon; Xiao Ling Jin; Bok Luel Lee; Nam-Chul Ha
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue.

Authors:  Wenjing Zhao; Marie-Line Garron; Bo Yang; Zhongping Xiao; Jeffrey D Esko; Miroslaw Cygler; Robert J Linhardt
Journal:  FEBS Lett       Date:  2011-07-06       Impact factor: 4.124

3.  Sulfate homeostasis. II. Influence of chronic aspirin administration on inorganic sulfate in humans.

Authors:  M E Morris; L J Benincosa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

4.  The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.

Authors:  Benjamin Richard; Richard Swanson; Steven T Olson
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

5.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

6.  Developmental differences in renal sulfate reabsorption: transport kinetics in brush border membrane vesicles.

Authors:  D R Pena; R E Neiberger
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

7.  Antithrombin: An anticoagulant, anti-inflammatory and antibacterial serpin.

Authors:  Alireza R Rezaie; Hemant Giri
Journal:  J Thromb Haemost       Date:  2020-03       Impact factor: 5.824

Review 8.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

9.  Update on the safety and bioequivalence of biosimilars - focus on enoxaparin.

Authors:  Walter Jeske; Jeanine M Walenga; Debra Hoppensteadt; Jawed Fareed
Journal:  Drug Healthc Patient Saf       Date:  2013-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.